Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group

Transplant Proc. 1996 Aug;28(4):2183-6.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Blood Pressure
  • Creatinine / blood
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects*
  • Double-Blind Method
  • Female
  • Graft Rejection / epidemiology
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine